Clin2
NCT07363382Likely a fitRecruiting

Testing GRPR PET Scan for Prostate Cancer

Prostate Cancer (Adenocarcinoma)

Part of Cancer, Kidney & urinary clinical trials.

This study tests a new imaging method (GRPR PET) to help better see and stage prostate cancer. If you have prostate cancer, this scan may give doctors more detail about where the cancer is located.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
6 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You have prostate cancer, whether you have been treated before or not.
  • You are willing to sign a consent form agreeing to take part in the study.
  • You do not have a known allergy to PSMA (the imaging agent used in this study).
  • You do not have any medical condition that would keep you from following the study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07209878Recruiting· Phase 2/Phase 3
PET scan vs. MRI for prostate cancer diagnosis

This trial compares two types of imaging scans (a PSMA PET scan and an MRI) to see which is better at finding prostate cancer. You may be able to join if you are scheduled for prostate removal surgery and haven't started cancer treatment yet.

Fuzhou, Fujian
NCT07747493Not yet recruiting
PSMA PET/MRI to guide treatment for prostate cancer

This trial uses a special imaging test (PET/MRI) to look at prostate cancer in detail before surgery. The goal is to see if this imaging can help choose the best treatment, possibly sparing healthy tissue.

Toronto, Ontario
NCT06696326Recruiting
New PET scan for prostate cancer detection

This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.

Xiamen, Fujian
NCT06494696Recruiting
PSMA PET/MRI with MRI for prostate cancer risk

This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.

Taoyuan City
NCT07242014Recruiting
New PET scan for prostate cancer

This trial tests a new PET scan called XACP3 to see if it can find prostate cancer as well as the standard PSMA PET scan. You could help by having both scans to compare them.

Xiamen, Fujian
NCT07615101Recruiting· Phase 3
PET scan imaging test for newly diagnosed prostate cancer

This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.

Nanjing, Jiangsu

Hear when a new Prostate Cancer (Adenocarcinoma) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.